Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8162826rdf:typepubmed:Citationlld:pubmed
pubmed-article:8162826lifeskim:mentionsumls-concept:C1336708lld:lifeskim
pubmed-article:8162826lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:8162826lifeskim:mentionsumls-concept:C0028609lld:lifeskim
pubmed-article:8162826lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:8162826lifeskim:mentionsumls-concept:C0016263lld:lifeskim
pubmed-article:8162826lifeskim:mentionsumls-concept:C1293950lld:lifeskim
pubmed-article:8162826lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:8162826pubmed:issue1lld:pubmed
pubmed-article:8162826pubmed:dateCreated1994-5-24lld:pubmed
pubmed-article:8162826pubmed:abstractTextWe studied 41 testicular germ cell tumors (TGCT) using DNA flow cytometry and argyrophilic (silver staining) nucleolar organizer region (Ag-NOR) quantitation to evaluate the proliferative characteristics of TGCT and the significance of those analytical techniques. In nonseminomatous germ cell tumor (NSGCT), the percentage of S + G2M phase cells (%S + G2M) in DNA aneuploid tumor was higher than in DNA of diploid tumors. Likewise, in NSGCT the aneuploid Ag-NOR sites per nucleus (Ag-NOR count) were significantly higher in DNA aneuploid than in DNA diploid tumors. There was also a significant linear correlation between % S + G2M phase cells and the Ag-NOR count in TGCT. However, the DNA ploidy pattern and the % S + G2M phase cells, and Ag-NOR counts, did not correlate significantly with the patient survival rate or clinical stage. In conclusion, our study suggests that Ag-NOR enumeration is an effective technique for assessing cellular proliferative activity that is somewhat less expensive than DNA flow cytometry.lld:pubmed
pubmed-article:8162826pubmed:languageenglld:pubmed
pubmed-article:8162826pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8162826pubmed:citationSubsetIMlld:pubmed
pubmed-article:8162826pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8162826pubmed:statusMEDLINElld:pubmed
pubmed-article:8162826pubmed:monthJanlld:pubmed
pubmed-article:8162826pubmed:issn0196-4763lld:pubmed
pubmed-article:8162826pubmed:authorpubmed-author:HasegawaSSlld:pubmed
pubmed-article:8162826pubmed:authorpubmed-author:SakamotoHHlld:pubmed
pubmed-article:8162826pubmed:authorpubmed-author:OkamuraKKlld:pubmed
pubmed-article:8162826pubmed:authorpubmed-author:YamakawaYYlld:pubmed
pubmed-article:8162826pubmed:authorpubmed-author:ShimojiTTlld:pubmed
pubmed-article:8162826pubmed:authorpubmed-author:MiyakeKKlld:pubmed
pubmed-article:8162826pubmed:issnTypePrintlld:pubmed
pubmed-article:8162826pubmed:day1lld:pubmed
pubmed-article:8162826pubmed:volume15lld:pubmed
pubmed-article:8162826pubmed:ownerNLMlld:pubmed
pubmed-article:8162826pubmed:authorsCompleteYlld:pubmed
pubmed-article:8162826pubmed:pagination59-63lld:pubmed
pubmed-article:8162826pubmed:dateRevised2007-9-4lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:meshHeadingpubmed-meshheading:8162826-...lld:pubmed
pubmed-article:8162826pubmed:year1994lld:pubmed
pubmed-article:8162826pubmed:articleTitleEvaluation of testicular germ cell tumor proliferation using DNA flow cytometry and nucleolar organizer silver staining.lld:pubmed
pubmed-article:8162826pubmed:affiliationDepartment of Urology, Nagoya University School of Medicine, Japan.lld:pubmed
pubmed-article:8162826pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8162826pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8162826lld:pubmed